colistimethate sodium has been researched along with sulbactam in 1 studies
| Studies (colistimethate sodium) | Trials (colistimethate sodium) | Recent Studies (post-2010) (colistimethate sodium) | Studies (sulbactam) | Trials (sulbactam) | Recent Studies (post-2010) (sulbactam) |
|---|---|---|---|---|---|
| 188 | 12 | 140 | 1,844 | 297 | 488 |
| Protein | Taxonomy | colistimethate sodium (IC50) | sulbactam (IC50) |
|---|---|---|---|
| Beta-lactamase | Escherichia coli | 6.2 | |
| Beta-lactamase | Shouchella clausii | 0.075 | |
| Beta-lactamase | Pseudomonas aeruginosa | 0.37 | |
| Beta-lactamase | Pseudomonas aeruginosa | 3 | |
| Beta-lactamase | Aeromonas allosaccharophila | 4 | |
| Beta-lactamase | Staphylococcus aureus | 6.5 | |
| Beta-lactamase | Enterobacter cloacae | 1.4 | |
| Beta-lactamase TEM | Escherichia coli | 4.3 | |
| Beta-lactamase | Acinetobacter pittii | 1.12 | |
| Beta-lactamase | Acinetobacter pittii | 7.758 | |
| Beta-lactamase | Pseudomonas aeruginosa | 3 | |
| Beta-lactamase | Escherichia coli | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, L; Li, H; Li, X; Liu, J; Luo, S; Wan, Z; Wang, Y; Wu, X; Xie, X; Zhao, Z | 1 |
1 other study(ies) available for colistimethate sodium and sulbactam
| Article | Year |
|---|---|
In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli.
Topics: Acinetobacter baumannii; Administration, Intravenous; Animals; Anti-Bacterial Agents; Biofilms; Colistin; Disease Models, Animal; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Monte Carlo Method; Sulbactam; Treatment Outcome; Urinary Tract Infections | 2020 |